RU2007126770A - Кристаллические формы ингибитора фактора ха - Google Patents

Кристаллические формы ингибитора фактора ха Download PDF

Info

Publication number
RU2007126770A
RU2007126770A RU2007126770/04A RU2007126770A RU2007126770A RU 2007126770 A RU2007126770 A RU 2007126770A RU 2007126770/04 A RU2007126770/04 A RU 2007126770/04A RU 2007126770 A RU2007126770 A RU 2007126770A RU 2007126770 A RU2007126770 A RU 2007126770A
Authority
RU
Russia
Prior art keywords
pyridin
crystalline
powder
ray diffractogram
following
Prior art date
Application number
RU2007126770/04A
Other languages
English (en)
Russian (ru)
Inventor
Майкл Дж. ОРВЭТ (US)
Майкл Дж. ОРВЭТ
Мэри Ф. МЭЛЛИ (US)
Мэри Ф. МЭЛЛИ
Роксана Ф. СКЛЭМ (US)
Роксана Ф. СКЛЭМ
Стивен Р. ФЭБИАН (US)
Стивен Р. ФЭБИАН
Бинг-шиу ЙАНГ (US)
Бинг-шиу ЙАНГ
Виктор В. РОССО (US)
Виктор В. Россо
Original Assignee
Бристол-Маерс Сквибб Компани (Us)
Бристол-Маерс Сквибб Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бристол-Маерс Сквибб Компани (Us), Бристол-Маерс Сквибб Компани filed Critical Бристол-Маерс Сквибб Компани (Us)
Publication of RU2007126770A publication Critical patent/RU2007126770A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2007126770/04A 2004-12-15 2005-12-14 Кристаллические формы ингибитора фактора ха RU2007126770A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63638704P 2004-12-15 2004-12-15
US60/636,387 2004-12-15
US73798505P 2005-11-18 2005-11-18
US60/737,985 2005-11-18

Publications (1)

Publication Number Publication Date
RU2007126770A true RU2007126770A (ru) 2009-01-27

Family

ID=36384503

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007126770/04A RU2007126770A (ru) 2004-12-15 2005-12-14 Кристаллические формы ингибитора фактора ха

Country Status (15)

Country Link
US (2) US7371864B2 (cg-RX-API-DMAC7.html)
EP (1) EP1828187A2 (cg-RX-API-DMAC7.html)
JP (1) JP2008524228A (cg-RX-API-DMAC7.html)
KR (1) KR20070087606A (cg-RX-API-DMAC7.html)
AR (1) AR053990A1 (cg-RX-API-DMAC7.html)
AU (1) AU2005317158A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0519331A2 (cg-RX-API-DMAC7.html)
CA (1) CA2589886A1 (cg-RX-API-DMAC7.html)
IL (1) IL183825A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007006919A (cg-RX-API-DMAC7.html)
NO (1) NO20072666L (cg-RX-API-DMAC7.html)
PE (1) PE20060739A1 (cg-RX-API-DMAC7.html)
RU (1) RU2007126770A (cg-RX-API-DMAC7.html)
TW (1) TW200634011A (cg-RX-API-DMAC7.html)
WO (1) WO2006065853A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5588970B2 (ja) 2008-05-27 2014-09-10 ダコ・デンマーク・エー/エス ハイブリダイゼーション組成物及び方法
US9303287B2 (en) * 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
WO2013046033A1 (en) 2011-09-30 2013-04-04 Dako Denmark A/S Hybridization compositions and methods using formamide
EP3252173A1 (en) 2011-10-21 2017-12-06 Dako Denmark A/S Hybridization compositions and methods
UY38438A (es) 2018-11-02 2020-05-29 Biocryst Pharm Inc Sales cristalinas de un inhibidor de calicreína plasmática

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002341693B2 (en) * 2001-09-21 2008-05-29 Bristol-Myers Squibb Holdings Ireland Unlimited Company Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
TWI320039B (en) 2001-09-21 2010-02-01 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
US20060069260A1 (en) * 2004-09-28 2006-03-30 Huiping Zhang Preparation of N-aryl pyridones
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7388096B2 (en) * 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
US20060069085A1 (en) * 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
NO20072666L (no) 2007-09-07
JP2008524228A (ja) 2008-07-10
MX2007006919A (es) 2007-06-26
IL183825A0 (en) 2007-09-20
EP1828187A2 (en) 2007-09-05
BRPI0519331A2 (pt) 2009-01-20
WO2006065853A2 (en) 2006-06-22
TW200634011A (en) 2006-10-01
US20060148846A1 (en) 2006-07-06
CA2589886A1 (en) 2006-06-22
US7371864B2 (en) 2008-05-13
US20080188517A1 (en) 2008-08-07
WO2006065853A3 (en) 2006-08-24
PE20060739A1 (es) 2006-08-16
AU2005317158A1 (en) 2006-06-22
AR053990A1 (es) 2007-05-30
KR20070087606A (ko) 2007-08-28

Similar Documents

Publication Publication Date Title
HRP20201927T1 (hr) PIRIMIDINONI KAO INHIBITORI FAKTORA XIa
HRP20180465T1 (hr) Kristalni oblici inhibitora faktora xia
JP2014530240A5 (cg-RX-API-DMAC7.html)
JP2015533168A5 (cg-RX-API-DMAC7.html)
KR100204433B1 (ko) 4-아미노피리미딘 유도체
JP2014532070A5 (cg-RX-API-DMAC7.html)
JP2017504640A5 (cg-RX-API-DMAC7.html)
JP2011520967A5 (cg-RX-API-DMAC7.html)
JP2014521701A5 (cg-RX-API-DMAC7.html)
JP2017525744A5 (cg-RX-API-DMAC7.html)
RU2007116150A (ru) Полиморфные формы 6-[2-(метилкарбамоил)фенилсульфанил]-3-е-[2-[пиридин-2-ил)этенил]индазола
EP3360862B1 (en) Alkynyl pyridine prolyl hydroxylase inhibitor, and preparation method and medical use thereof
JP2006528621A5 (cg-RX-API-DMAC7.html)
JP2007517035A5 (cg-RX-API-DMAC7.html)
RU2006119776A (ru) Производные бензо{b}{1, 4} диоксепина
JP2018515525A5 (cg-RX-API-DMAC7.html)
CA2726020A1 (en) 2-alkoxy-substituted dicyanopyridines and use thereof
JP2006507355A5 (cg-RX-API-DMAC7.html)
RU2012108423A (ru) Ацилгуанидиновые производные с азотсодержащим циклом
JP2024507414A5 (cg-RX-API-DMAC7.html)
CZ20012627A3 (cs) Pouľití imidazo [1,5-a] pyrido [3,2-e]pyrazinonů jako léčiva
JP2018522024A5 (cg-RX-API-DMAC7.html)
WO2014055595A1 (en) Indoline compounds as aldosterone synthase inhibitiors related applications
RU2008119994A (ru) Ингибиторы калиевых каналов
CA1238046A (en) Dihydropyridyl cyclic imidate esters and their pharmaceutical use

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20090210